Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 236

1.

Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals.

Falagas ME, Skalidis T, Vardakas KZ, Voulgaris GL, Papanikolaou G, Legakis N; Hellenic TP-6076 Study Group.

Int J Antimicrob Agents. 2018 Aug;52(2):269-271. doi: 10.1016/j.ijantimicag.2018.03.009. Epub 2018 Mar 17.

PMID:
29559273
2.

Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.

Falagas ME, Skalidis T, Vardakas KZ, Legakis NJ; Hellenic Cefiderocol Study Group.

J Antimicrob Chemother. 2017 Jun 1;72(6):1704-1708. doi: 10.1093/jac/dkx049.

PMID:
28369471
3.

Aerococcus urinae, a cause of cystitis with malodorous urine in a child: clinical and microbiological challenges.

Skalidis T, Papaparaskevas J, Konstantinou D, Kapolou E, Falagas ME, Legakis N.

JMM Case Rep. 2017 Feb 28;4(2):e005083. doi: 10.1099/jmmcr.0.005083. eCollection 2017 Feb.

4.

Abnormal vaginal flora in symptomatic non-pregnant and pregnant women in a Greek hospital: a prospective study.

Tansarli GS, Skalidis T, Legakis NJ, Falagas ME.

Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):227-232. doi: 10.1007/s10096-016-2787-5. Epub 2016 Oct 13.

PMID:
27738857
5.

Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature.

Vardakas KZ, Legakis NJ, Triarides N, Falagas ME.

Int J Antimicrob Agents. 2016 Apr;47(4):269-85. doi: 10.1016/j.ijantimicag.2016.02.001. Epub 2016 Feb 24. Review.

PMID:
27013000
6.

Is there a connection between inflammation, telomerase activity and the transcriptional status of telomerase reverse transcriptase in renal failure?

Kordinas V, Tsirpanlis G, Nicolaou C, Zoga M, Ioannidis A, Ioannidou V, Bersimis S, Petrihou C, Savva L, Legakis NJ, Chatzipanagiotou S.

Cell Mol Biol Lett. 2015 Jun;20(2):222-36. doi: 10.1515/cmble-2015-0016.

PMID:
26204404
7.

Multilocus sequence typing (and phylogenetic analysis) of Campylobacter jejuni and Campylobacter coli strains isolated from clinical cases in Greece.

Ioannidou V, Ioannidis A, Magiorkinis E, Bagos P, Nicolaou C, Legakis N, Chatzipanagiotou S.

BMC Res Notes. 2013 Sep 8;6:359. doi: 10.1186/1756-0500-6-359.

8.

Differences in the epidemiology between paediatric and adult invasive Streptococcus pyogenes infections.

Zachariadou L, Stathi A, Tassios PT, Pangalis A, Legakis NJ, Papaparaskevas J; Hellenic Strep-Euro Study Group.

Epidemiol Infect. 2014 Mar;142(3):512-9. doi: 10.1017/S0950268813001386. Epub 2013 Jun 7.

PMID:
23746128
9.

Identification and antimicrobial resistance of campylobacter species isolated from animal sources.

Marinou I, Bersimis S, Ioannidis A, Nicolaou C, Mitroussia-Ziouva A, Legakis NJ, Chatzipanagiotou S.

Front Microbiol. 2012 Feb 24;3:58. doi: 10.3389/fmicb.2012.00058. eCollection 2012.

10.

Epidemiological characteristics of infections caused by Bacteroides, Prevotella and Fusobacterium species: a prospective observational study.

Papaparaskevas J, Katsandri A, Pantazatou A, Stefanou I, Avlamis A, Legakis NJ, Tsakris A.

Anaerobe. 2011 Jun;17(3):113-7. doi: 10.1016/j.anaerobe.2011.05.013. Epub 2011 Jun 2.

PMID:
21664284
11.

Sequence of pNL194, a 79.3-kilobase IncN plasmid carrying the blaVIM-1 metallo-beta-lactamase gene in Klebsiella pneumoniae.

Miriagou V, Papagiannitsis CC, Kotsakis SD, Loli A, Tzelepi E, Legakis NJ, Tzouvelekis LS.

Antimicrob Agents Chemother. 2010 Oct;54(10):4497-502. doi: 10.1128/AAC.00665-10. Epub 2010 Jul 26.

12.

In vitro bactericidal activity of human beta-defensin 2 against nosocomial strains.

Routsias JG, Karagounis P, Parvulesku G, Legakis NJ, Tsakris A.

Peptides. 2010 Sep;31(9):1654-60. doi: 10.1016/j.peptides.2010.06.010. Epub 2010 Jun 19.

PMID:
20600430
13.

The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2.

Zioga A, Miriagou V, Tzelepi E, Douzinas E, Tsakiri M, Legakis NJ, Daikos GL, Tzouvelekis LS.

Int J Antimicrob Agents. 2010 Aug;36(2):190-1. doi: 10.1016/j.ijantimicag.2010.04.002. Epub 2010 May 26. No abstract available.

PMID:
20510588
14.

GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.

Kotsakis SD, Papagiannitsis CC, Tzelepi E, Legakis NJ, Miriagou V, Tzouvelekis LS.

Antimicrob Agents Chemother. 2010 Mar;54(3):1331-3. doi: 10.1128/AAC.01561-09. Epub 2010 Jan 11.

15.

Detecting VIM-1 production in Proteus mirabilis by an imipenem-dipicolinic acid double disk synergy test.

Miriagou V, Papagiannitsis CC, Tzelepi E, Casals JB, Legakis NJ, Tzouvelekis LS.

J Clin Microbiol. 2010 Feb;48(2):667-8. doi: 10.1128/JCM.01872-09. Epub 2009 Dec 9. No abstract available.

16.

In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints.

Papaparaskevas J, Tzouvelekis LS, Tsakris A, Pittaras TE, Legakis NJ; Hellenic Tigecycline Study Group.

Diagn Microbiol Infect Dis. 2010 Feb;66(2):187-94. doi: 10.1016/j.diagmicrobio.2009.09.012.

PMID:
19836184
17.

Metastatic melanoma of the gallbladder: an unusual clinical presentation of acute cholecystitis.

Vernadakis S, Rallis G, Danias N, Serafimidis C, Christodoulou E, Troullinakis M, Legakis N, Peros G.

World J Gastroenterol. 2009 Jul 21;15(27):3434-6.

18.

Multiplex PCR for the discrimination of A. fumigatus, A. flavus, A. niger and A. terreus.

Logotheti M, Kotsovili-Tseleni A, Arsenis G, Legakis NI.

J Microbiol Methods. 2009 Feb;76(2):209-11. doi: 10.1016/j.mimet.2008.10.006. Epub 2008 Oct 27.

PMID:
18992777
19.

Prospective monitoring of BK virus replication in renal transplant recipients.

Koukoulaki M, Grispou E, Pistolas D, Balaska K, Apostolou T, Anagnostopoulou M, Tseleni-Kotsovili A, Hadjiconstantinou V, Paniara O, Saroglou G, Legakis N, Drakopoulos S.

Transpl Infect Dis. 2009 Feb;11(1):1-10. doi: 10.1111/j.1399-3062.2008.00342.x. Epub 2008 Sep 21.

PMID:
18811631
20.

Emergence of Serratia liquefaciens and Klebsiella oxytoca with metallo-beta-lactamase-encoding IncW plasmids: further spread of the blaVIM-1-carrying integron In-e541.

Miriagou V, Douzinas EE, Papagiannitsis CC, Piperaki E, Legakis NJ, Tzouvelekis LS.

Int J Antimicrob Agents. 2008 Dec;32(6):540-1. doi: 10.1016/j.ijantimicag.2008.06.022. Epub 2008 Sep 10. No abstract available.

PMID:
18786812
21.

Prevalence of emm types 1 and 12 from invasive Streptococcus pyogenes disease in Greece--results of enhanced surveillance.

Stathi A, Papaparaskevas J, Zachariadou L, Pangalis A, Legakis NJ, Tseleni-Kotsovili A; Hellenic Strep-EURO Study Group, Tassios PT.

Clin Microbiol Infect. 2008 Aug;14(8):808-12. doi: 10.1111/j.1469-0691.2008.02032.x.

22.

Comparison of penile skin swab with intra-urethral swab and first void urine for polymerase chain reaction-based diagnosis of Chlamydia trachomatis urethritis in male patients.

Pittaras TE, Papaparaskevas J, Houhoula DP, Legakis NJ, Frangouli E, Katsambas A, Tsakris A, Papadogeorgakis H.

Sex Transm Dis. 2008 Dec;35(12):999-1001. doi: 10.1097/OLQ.0b013e318182a586. No abstract available.

PMID:
18665017
23.

Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece.

Papaparaskevas J, Pantazatou A, Katsandri A, Houhoula DP, Legakis NJ, Tsakris A, Avlamis A.

J Antimicrob Chemother. 2008 Jul;62(1):137-41. doi: 10.1093/jac/dkn134. Epub 2008 Apr 1.

PMID:
18385145
24.

Detection of chromosomal and plasmid--encoded virulence determinants in Yersinia enterocolitica and other Yersinia spp. isolated from food animals in Greece.

Kechagia N, Nicolaou C, Ioannidou V, Kourti E, Ioannidis A, Legakis NJ, Chatzipanagiotou S.

Int J Food Microbiol. 2007 Sep 30;118(3):326-31. Epub 2007 Aug 6.

PMID:
17825934
25.

Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection.

Cookson BD, Robinson DA, Monk AB, Murchan S, Deplano A, de Ryck R, Struelens MJ, Scheel C, Fussing V, Salmenlinna S, Vuopio-Varkila J, Cuny C, Witte W, Tassios PT, Legakis NJ, van Leeuwen W, van Belkum A, Vindel A, Garaizar J, Haeggman S, Olsson-Liljequist B, Ransjo U, Muller-Premru M, Hryniewicz W, Rossney A, O'Connell B, Short BD, Thomas J, O'Hanlon S, Enright MC.

J Clin Microbiol. 2007 Jun;45(6):1830-7. Epub 2007 Apr 11.

26.

Serologic prevalence of coxsackievirus group B in Greece.

Mavrouli MD, Spanakis N, Levidiotou S, Politi C, Alexiou S, Tseliou P, Hatzitaki M, Foundouli K, Tsakris A, Legakis NJ, Routsias JG.

Viral Immunol. 2007 Spring;20(1):11-8.

PMID:
17425417
27.

Genotyping of human Campylobacter jejuni isolates in Greece by pulsed-field gel electrophoresis.

Ioannidis A, Nicolaou C, Legakis NJ, Ioannidou V, Papavasileiou E, Voyatzi A, Chatzipanagiotou S.

Mol Diagn Ther. 2006;10(6):391-6.

PMID:
17154656
28.

The first database comprised of flagellin gene (flaA) types of Campylobacter jejuni human clinical isolates from Greece.

Ioannidis A, Nicolaou C, Legakis NJ, Ioannidou V, Chatzipanagiotou S.

Eur J Epidemiol. 2006;21(11):823-9. Epub 2006 Nov 17.

PMID:
17111250
29.

Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit.

Horianopoulou M, Legakis NJ, Kanellopoulou M, Lambropoulos S, Tsakris A, Falagas ME.

J Med Microbiol. 2006 Oct;55(Pt 10):1435-1439. doi: 10.1099/jmm.0.46713-0.

PMID:
17005794
30.

Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease.

Dimitroulia E, Spanakis N, Konstantinidou AE, Legakis NJ, Tsakris A.

Inflamm Bowel Dis. 2006 Sep;12(9):879-84.

PMID:
16954807
31.

Discordance of meropenem versus imipenem activity against Acinetobacter baumannii.

Ikonomidis A, Pournaras S, Maniatis AN, Legakis NJ, Tsakris A.

Int J Antimicrob Agents. 2006 Oct;28(4):376-7. Epub 2006 Sep 1. No abstract available.

PMID:
16949256
32.

Prevalence of infection by HTLV-I/II among pregnant women and high-risk groups in the Peloponnese peninsula, Greece.

Tseliou PM, Spanakis N, Spiliotakara A, Markogiannakis A, Legakis NJ, Tsakris A.

Int J STD AIDS. 2006 Aug;17(8):543-6.

PMID:
16925902
33.

VIM-1 metallo-beta-lactamase in Acinetobacter baumannii.

Tsakris A, Ikonomidis A, Pournaras S, Tzouvelekis LS, Sofianou D, Legakis NJ, Maniatis AN.

Emerg Infect Dis. 2006 Jun;12(6):981-3.

34.

Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolated from children in Greece during 2001-2004.

Paraskakis I, Kafetzis DA, Chrisakis A, Papavasilliou H, Kirikou H, Pangalis A, Tzouvelekis LS, Athanasiou T, Legakis NJ; National Surveillance Network for Pneumococcal Resistance.

Clin Microbiol Infect. 2006 May;12(5):490-3.

35.

In vitro activities of tigecycline against recently isolated Gram-negative anaerobic bacteria in Greece, including metronidazole-resistant strains.

Katsandri A, Avlamis A, Pantazatou A, Petrikkos GL, Legakis NJ, Papaparaskevas J; Hellenic Study Group for Gram-Negative Anaerobic Bacteria.

Diagn Microbiol Infect Dis. 2006 Jul;55(3):231-6. Epub 2006 Apr 19.

PMID:
16626904
36.

Idiopathic sclerosing encapsulating peritonitis (or abdominal cocoon).

Serafimidis C, Katsarolis I, Vernadakis S, Rallis G, Giannopoulos G, Legakis N, Peros G.

BMC Surg. 2006 Feb 13;6:3.

37.

Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.

Pournaras S, Markogiannakis A, Ikonomidis A, Kondyli L, Bethimouti K, Maniatis AN, Legakis NJ, Tsakris A.

J Antimicrob Chemother. 2006 Mar;57(3):557-61. Epub 2006 Jan 23.

PMID:
16431857
38.

VIM-12, a novel plasmid-mediated metallo-beta-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid.

Pournaras S, Ikonomidis A, Tzouvelekis LS, Tokatlidou D, Spanakis N, Maniatis AN, Legakis NJ, Tsakris A.

Antimicrob Agents Chemother. 2005 Dec;49(12):5153-6.

39.

Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.

Papaparaskevas J, Pantazatou A, Katsandri A, Legakis NJ, Avlamis A; Hellenic Study Group for Gram-Negative Anaerobic Bacteria.

Clin Microbiol Infect. 2005 Oct;11(10):820-4.

40.

Spread of efflux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity.

Pournaras S, Maniati M, Spanakis N, Ikonomidis A, Tassios PT, Tsakris A, Legakis NJ, Maniatis AN.

J Antimicrob Chemother. 2005 Oct;56(4):761-4. Epub 2005 Aug 22.

PMID:
16115825
41.

Absence of the plasmid-mediated quinolone resistance qnrA gene among Campylobacter jejuni clinical isolates from Greece.

Chatzipanagiotou S, Ioannidou V, Ioannidis A, Nicolaou C, Papavasileiou E, Chaniotaki S, Vatopoulos A, Tzouvelekis L, Legakis NJ.

Int J Antimicrob Agents. 2005 Sep;26(3):261-2. No abstract available.

PMID:
16099626
42.

Repeated occurrence of diverse extended-spectrum beta-lactamases in minor serotypes of food-borne Salmonella enterica subsp. enterica.

Politi L, Tassios PT, Lambiri M, Kansouzidou A, Pasiotou M, Vatopoulos AC, Mellou K, Legakis NJ, Tzouvelekis LS.

J Clin Microbiol. 2005 Jul;43(7):3453-6.

43.

Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor.

Christakis GB, Perlorentzou SP, Chalkiopoulou I, Athanasiou A, Legakis NJ.

J Clin Microbiol. 2005 Apr;43(4):2021-3.

44.

Coxsackievirus B3 sequences in the myocardium of fatal cases in a cluster of acute myocarditis in Greece.

Spanakis N, Manolis EN, Tsakris A, Tsiodras S, Panagiotopoulos T, Saroglou G, Legakis NJ.

J Clin Pathol. 2005 Apr;58(4):357-60.

45.

Chlamydia trachomatis infections in Greece: first prevalence study using nucleic acid amplification tests.

Levidiotou S, Vrioni G, Papadogeorgaki H, Avdeliodi K, Kada H, Kaparos G, Kouskouni E, Fragouli E, Legakis NJ.

Eur J Clin Microbiol Infect Dis. 2005 Mar;24(3):207-13.

PMID:
15776253
46.

Investigation of possible cytokine induction in peripheral blood mononuclear cells by heat-stable serotypes of Campylobacter jejuni.

Chatzipanagiotou S, Michalopoulou M, Marinou I, Boufidou F, Papavasileiou E, Trikka-Graphakos E, Kabouri E, Nicolaou C, Legakis NJ.

Clin Microbiol Infect. 2005 Jan;11(1):63-5.

47.

Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates.

Giakkoupi P, Tzouvelekis LS, Daikos GL, Miriagou V, Petrikkos G, Legakis NJ, Vatopoulos AC.

J Clin Microbiol. 2005 Jan;43(1):494-6.

48.

Detection of chromosomal- and plasmid-encoded virulence-associated epidemiological markers in Yersinia enterocolitica strains isolated from clinical cases: a comparative study.

Chatzipanagiotou S, Kyriazi Z, Ioannidis A, Trikka-Graphakos E, Nicolaou C, Legakis NJ.

Mol Diagn. 2004;8(2):131-2. No abstract available.

PMID:
15527328
49.

Ruling out Bacillus anthracis.

Papaparaskevas J, Houhoula DP, Papadimitriou M, Saroglou G, Legakis NJ, Zerva L.

Emerg Infect Dis. 2004 Apr;10(4):732-5.

50.

Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella.

Miriagou V, Tassios PT, Legakis NJ, Tzouvelekis LS.

Int J Antimicrob Agents. 2004 Jun;23(6):547-55. Review.

PMID:
15194124

Supplemental Content

Loading ...
Support Center